A study on prescriptions contributing to the risk of high anticholinergic burden in adults with intellectual disabilities: retrospective record linkage study

[1] Axmon A(2017)Prescription of potentially inappropriate medications among older people with intellectual disability: a register study BMC Pharmacol Toxicol 18 1-10

[2] Sandberg M(2016)Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study Br J Psychiatry 209 504-510

[3] Ahlström G(2018)Anticholinergic burden in adult and elderly people with intellectual disabilities: results from an Italian multicenter cross-sectional study PLoS ONE 13 1-16

[4] O’Dwyer M(2021)Risk of anticholinergic burden in adults with intellectual disabilities: a Scottish retrospective cohort study of n = 17 220 J Intellect Disabil Res 49 939-947

[5] Maidment ID(2020)Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis Age Ageing 296 1858-1483

[6] Bennett K(2006)National surveillance of emergency department visits for outpatient adverse drug events JAMA 59 1477-335

[7] De Vreese LP(2011)Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study J Am Geriatr Soc 76 319-155

[8] Mantesso U(2020)Association between anticholinergic drug burden and mortality in older people: a systematic review Eur J Clin Pharmacol 18 148-121

[9] De Bastiani E(2020)Assessing risks of polypharmacy involving medications with anticholinergic properties Ann Fam Med 16 110-130

[10] Ward LM(2015)Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis BMC Fam Pract 8 e018292-1460

[1] Axmon A(2017)Prescription of potentially inappropriate medications among older people with intellectual disability: a register study BMC Pharmacol Toxicol 18 1-10

[2] Sandberg M(2016)Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study Br J Psychiatry 209 504-510

[3] Ahlström G(2018)Anticholinergic burden in adult and elderly people with intellectual disabilities: results from an Italian multicenter cross-sectional study PLoS ONE 13 1-16

[4] O’Dwyer M(2021)Risk of anticholinergic burden in adults with intellectual disabilities: a Scottish retrospective cohort study of n = 17 220 J Intellect Disabil Res 49 939-947

[5] Maidment ID(2020)Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis Age Ageing 296 1858-1483

[6] Bennett K(2006)National surveillance of emergency department visits for outpatient adverse drug events JAMA 59 1477-335

[7] De Vreese LP(2011)Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study J Am Geriatr Soc 76 319-155

[8] Mantesso U(2020)Association between anticholinergic drug burden and mortality in older people: a systematic review Eur J Clin Pharmacol 18 148-121

[9] De Bastiani E(2020)Assessing risks of polypharmacy involving medications with anticholinergic properties Ann Fam Med 16 110-130

[10] Ward LM(2015)Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis BMC Fam Pract 8 e018292-1460